{
    "startDate": "2020-01-01",
    "endDate": "2020-03-31",
    "year": "2020",
    "quarter": "Q1",
    "symbol": "LIFE",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 39453000
            },
            {
                "label": "Available-for-sale investments",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 10376000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 545000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 50374000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 1281000
            },
            {
                "label": "Right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 2643000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 149000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 54447000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 748000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1908000
            },
            {
                "label": "Contract liability",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 143000
            },
            {
                "label": "Current portion of operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 780000
            },
            {
                "label": "Current portion of long-term debt, net of issuance costs and discount",
                "concept": "LongTermDebtCurrent",
                "unit": "usd",
                "value": 6866000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 10445000
            },
            {
                "label": "Long-term operating lease liability, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 2035000
            },
            {
                "label": "Commitments and contingencies (Note 4)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.001 par value per share; 10,714,286 authorized shares; issued and outstanding shares \u2013 9,352,498 and 3,891,787 as of March 31, 2020 (unaudited) and December 31, 2019, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 9000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 362723000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -53000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -320551000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 42128000
            },
            {
                "label": "Noncontrolling interest in Pangu BioPharma Limited",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -161000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 41967000
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 54447000
            }
        ],
        "cf": [
            {
                "label": "Consolidated net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 1752000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 157000
            },
            {
                "label": "Stock-based compensation",
                "concept": "AllocatedShareBasedCompensationExpense",
                "unit": "usd",
                "value": 423000
            },
            {
                "label": "Debt discount accretion and non-cash interest expense",
                "concept": "AccretionExpense",
                "unit": "usd",
                "value": 129000
            },
            {
                "label": "Accretion of discount of available-for-sale investment securities",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": 24000
            },
            {
                "label": "Operating lease right of use asset amortization.",
                "concept": "life:OperatingLeaseRightOfUseAssetAmortization",
                "unit": "usd",
                "value": 201000
            },
            {
                "label": "Loss on disposal of property and equipment",
                "concept": "GainLossOnSaleOfPropertyPlantEquipment",
                "unit": "usd",
                "value": -6000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -236000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -578000
            },
            {
                "label": "Contract liability",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": -65000
            },
            {
                "label": "Increase (decrease) in operating lease liability.",
                "concept": "life:IncreaseDecreaseInOperatingLeaseLiability",
                "unit": "usd",
                "value": -179000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 2058000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 166000
            },
            {
                "label": "Purchases of available-for-sale investment securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 3081000
            },
            {
                "label": "Maturities of available-for-sale investment securities",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 14650000
            },
            {
                "label": "Proceeds from sale of property and equipment",
                "concept": "ProceedsFromSaleOfPropertyPlantAndEquipment",
                "unit": "usd",
                "value": 3000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 11406000
            },
            {
                "label": "Proceeds from issuance of common stock through underwritten follow-on offering, net of offering costs.",
                "concept": "life:ProceedsFromIssuanceOfCommonStockThroughUnderwrittenFollowOnOfferingNetOfOfferingCosts",
                "unit": "usd",
                "value": 18779000
            },
            {
                "label": "Repayments on borrowings",
                "concept": "RepaymentsOfDebt",
                "unit": "usd",
                "value": 2000000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 16779000
            },
            {
                "label": "Net change in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 30243000
            }
        ],
        "ic": [
            {
                "label": "Total revenues",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 8065000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 3616000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2590000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 6206000
            },
            {
                "label": "Income (loss) from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 1859000
            },
            {
                "label": "Total other expense, net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -107000
            },
            {
                "label": "Consolidated net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 1752000
            },
            {
                "label": "Net loss attributable to noncontrolling interest in Pangu BioPharma Limited",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1000
            },
            {
                "label": "Net loss attributable to noncontrolling interest in Pangu BioPharma Limited",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 1753000
            },
            {
                "label": "Basic net income (loss) per share",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 0.25
            },
            {
                "label": "Shares used in computing basic net income (loss) per share",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 6881791
            },
            {
                "label": "Diluted net income (loss) per share",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 0.25
            },
            {
                "label": "Shares used in computing diluted net income (loss) per share",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 6884797
            },
            {
                "label": "Change in unrealized gain (loss) on available-for-sale investments, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -13000
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 1739000
            },
            {
                "label": "Comprehensive loss attributable to noncontrolling interest Pangu BioPharma Limited",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1000
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 1740000
            }
        ]
    }
}